来自视网膜退化血统的整个基因组的敏度测序可以识别因果变异
Pooja Biswas1, Adda Villanueva2, Benjamin J Krajacich3
1Department of Ophthalmology, Shiley Eye Institute, University of California at San Diego, San Diego, California, United States of America.
PloS one
|October 4, 2024
概括
敏度测序有效地识别罕见疾病变体. 这种全基因组测序方法在遗传性视网膜退化病例中实现了50%的诊断产量,精确确定了关键基因中的因果变异.
科学领域:
- 基因组学就是基因组学.
- 眼科医生 眼科 眼科
- 罕见疾病 罕见疾病
背景情况:
- 全基因组测序 (WGS) 对于识别罕见疾病变异至关重要.
- 遗传性视网膜退化 (IRD) 代表了一大批罕见的遗传性疾病.
研究的目的:
- 评估一种用于罕见疾病诊断的新型狂热度测序方法.
- 评估在患有遗传性视网膜退行症的家庭中,贪性测序的诊断效用.
主要方法:
- 开发了一个全面的WGS工作流程,将狂热度测序与标准准备和分析工具集成在一起.
- 将工作流应用于展示IRD表型的十种血统.
- 进行隔离分析以验证受影响家庭成员的候选变异.
主要成果:
- 在十分之五的IRD病例中确定了潜在的因果变异 (50%的诊断收益率).
- 在已知的IRD基因中检测到高可信度变异,包括ABCA4,CERKL,MAK,PEX6和RDH12.
- 观察到的结果与之前的IRD诊断产量一致.
结论:
- 敏度测序是一种适合和有效的全基因组测序方法,用于罕见疾病的应用.
- 开发的工作流程显示了诊断IRD等遗传眼病的潜力.
- 对于已识别的变体,正在等待进一步的临床验证.
相关概念视频
Pedigree Analysis
84.1K
Overview
84.1K
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K


